Luis Veloza

CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma

David Martin‐García, Alba Navarro, Rafael Valdés‐Mas et al. · Blood · 2018 · 112 citations · Full text

Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome

Luis Veloza, Doriane Cavalieri, Edoardo Missiaglia et al. · Haematologica · 2022 · 66 citations · Full text

Mixed-phenotype Acute Leukemia, T-regulatory Cell, Immunology +17

SOX11, CD70, and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma

Patricia Balsas, Luis Veloza, Guillem Clot et al. · Blood · 2021 · 52 citations · Full text

Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience

Pablo Mozas, Ferran Nadeu, Alfredo Rivas‐Delgado et al. · Blood Cancer Journal · 2020 · 34 citations · Full text

Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death‐ligand 1 (PD‐L1) axis in post‐transplant lymphoproliferative disorders: association with Epstein–Barr virus, <i>PD‐L1</i> copy number alterations, and outcome

Luis Veloza, Cristina Teixidó, Natalia Castrejón de Anta et al. · Histopathology · 2019 · 29 citations